LexDanaLexDanabeta
Inventor

Shifeng Pan

Inventor
San Diego, CA, US

Overview

57→
Patents
2005–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 57 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07DHeterocyclic compounds23%
A01HNew plants or non-transgenic processes for obtaining them22%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds6%
A01NPreservation of bodies of humans or animals or plants or parts thereof3%
Y02ATechnologies for adaptation to climate change2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07KPeptides2%
C12NMicroorganisms or enzymes2%
PatentTitleYear
PP031819None2020PP030518None201910,280,139Cytotoxic peptides and conjugates thereof201910,251,893N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as Wnt signaling modulators2019PP030189None2019PP030188None2019PP029655None2018PP029653None2018PP029654None2018PP029373None20189,884,817'Auristatin derivatives and conjugates thereof'2018PP028174'Lantana plant named ‘LANZ0007’'2017PP028175'Lantana plant named ‘LANZ0008’'20179,580,426'Compounds that expand hematopoietic stem cells'2017PP027427'Lantana plant named ‘LANZ0011’'2016PP027379'Lantana plant named ‘LANZ0009’'20169,238,646'N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as WNT signaling modulators'20169,216,964'Hedgehog pathway modulators'20159,181,235'Substituted pyridines for modulating the WNT signaling pathway'20159,181,238'N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitors'20158,927,281'Method for expanding hematopoietic stem cells'20158,778,927'Smoothened antagonism for the treatment of hedgehog pathway-related disorders'2014PP024641'Lantana plant named ‘LANZ0004’'20148,546,396'N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulators'20138,507,491'Compounds and compositions as hedgehog pathway inhibitors'2013PP023340'Lantana plant named ‘LANZ0001’'2013PP023317'Lantana plant named ‘LANZ0002’'2013PP023316'Lantana plant named ‘LANZ0003’'20138,202,876'Compounds and compositions as protein kinase inhibitors'20128,178,563'Compounds and compositions as hedgehog pathway modulators'20128,178,526'Compounds and compositions as ITPKb inhibitors'20127,939,519'Immunosuppresant compounds and compositions'20117,928,133'Compounds and compositions as hedgehog signaling pathway modulators'2011PP021617'Lantana plant named ‘Bani Yelbic’'2011PP021616'Lantana plant named ‘Bani Rossa’'2011PP021590'Lantana plant named ‘Ban Whit’'2010PP021452'Lantana plant named ‘Bani Redda’'20107,750,021'Immunosuppressant compounds and compositions'20107,718,704'Immunosuppressant compounds and compositions'20107,638,523'Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors'2009PP020555'Lantana plant named ‘Bant Pin09’'2009PP020557'Lantana plant named ‘Bant Tragol’'2009PP020531'Lantana plant named ‘Bant Reda09’'20097,592,349'Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors'20097,572,811'Immunosuppressant compounds and compositions'20097,563,894'Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors'20097,514,447'Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors'20097,462,629'Immunosuppressant compounds and compositions'2008PP019264'Lantana plant named ‘Bante Cheriasun’'20087,417,065'Immunosuppressant compounds and compositions'2008PP019078'Lantana plant named ‘Bante oransun’'2008PP018148'Lantana plant named ‘Bante Rossa’'2007PP018115'Lantana plant named ‘Bante Cheria’'20077,256,206'Bicyclic compounds and compositions'20077,169,817'Bis-aromatic alkanols'20077,060,697'Immunosuppressant compounds and compositions'20066,861,533'Solution phase sythesis of arylbenzoxazoles'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2015Patents assigned to IRM LLC (20)· patent assignee history
2005–2019Based in San Diego, CA, US· patent location history
2007–2011Based in Hollister, CA, US· patent location history
2009–2019Patents assigned to NOVARTIS AG (15)· patent assignee history
2009–2020Patents assigned to SYNGENTA CROP PROTECTION AG (11)· patent assignee history
2012–2018Patents assigned to PAN SHIFENG (17)· patent assignee history
2013–2020Based in Gilroy, CA, US· patent location history
2016–2019Patents assigned to SYNGENTA PARTICIPATIONS AG (11)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
IRM LLC202005–2015
PAN SHIFENGself172012–2018
NOVARTIS AG152009–2019
SYNGENTA CROP PROTECTION AG112009–2020
SYNGENTA PARTICIPATIONS AG112016–2019
Locations
LocationPatentsSpan
San Diego, California, US302005–2019
Gilroy, California, US162013–2020
Hollister, California, US112007–2011